FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum

Song, Wenpeng; Wang, Jian; Gong, Shixin; Wang, Xiaoyan; Xu, Junji; Wu, Ruiqing; Jiang, Zongmin; Zhang, Huiyuan; Wu, Lida; Wang, Yilong; Su, Yingying; Wang, Hao; Gu, Yuchun

doi:10.7150/thno.142919

PDF

Theranostics 2026; 16(16):9557-9558. doi:10.7150/thno.142919 This issue Cite

Erratum

FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum

Wenpeng Song¹, Jian Wang⁴, Shixin Gong⁴, Xiaoyan Wang^1,5, Junji Xu⁶, Ruiqing Wu¹, Zongmin Jiang⁴, Huiyuan Zhang⁴, Lida Wu⁴, Yilong Wang^5,7, Yingying Su¹, Hao Wang¹, Yuchun Gu^2,3,4

1. Department of Stomatology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
2. Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
3. Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.
4. Research and Development Department, Allife Medicine Inc., Beijing, China.
5. Beijing Laboratory of Oral Health, Capital Medical University School of Stomatology, Beijing, China.
6. College of Stomatology, Chongqing Medical University, Chongqing, China.
7. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Published 2026-11-2

Citation:

Song W, Wang J, Gong S, Wang X, Xu J, Wu R, Jiang Z, Zhang H, Wu L, Wang Y, Su Y, Wang H, Gu Y. FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum. Theranostics 2026; 16(16):9557-9558. doi:10.7150/thno.142919. https://www.thno.org/v16p9557.htm

Other styles

Corrected-article in Theranostics, Volume 15, 7127

The authors regret that the original version of our manuscript contained several inadvertent errors regarding the representative images in Figures 1, 5, and 8. In Figure 1F, some images of iMSCs treated with DPBS (Ca-Mg-) at 37°C were not replaced as intended during figure preparation, resulting in the inadvertent use of incorrect images. In addition, due to an oversight during figure assembly, the fluorescence images in Figure 5 illustrating the differential expression of OCT4 between iPSCs and iMSCs were displayed incorrectly. Furthermore, Figures 7H and 8I represent the same treatment of the same cell type, and the corresponding images were inadvertently duplicated, which may have caused confusion in the interpretation of the figures. We therefore request replacement of the images in Figure 8I. The corrected versions of Figures 1, 5, and 8 are shown below. The authors confirm that the corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that these errors may have caused.

Figure A

Corrected Figure 1F.

Figure B

Corrected Figure 5B.

Figure C

Corrected Figure 8I.

Author contact

Corresponding authors: Yuchun Gu (Email: ycguedu.cn), Hao Wang (Email: Hao_Wang2022com) and YingYing Su (Email: reliayysucom).

Citation styles

APA

Song, W., Wang, J., Gong, S., Wang, X., Xu, J., Wu, R., Jiang, Z., Zhang, H., Wu, L., Wang, Y., Su, Y., Wang, H., Gu, Y. (2026). FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum. Theranostics, 16(16), 9557-9558. https://doi.org/10.7150/thno.142919.

ACS

Song, W.; Wang, J.; Gong, S.; Wang, X.; Xu, J.; Wu, R.; Jiang, Z.; Zhang, H.; Wu, L.; Wang, Y.; Su, Y.; Wang, H.; Gu, Y. FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum. Theranostics 2026, 16 (16), 9557-9558. DOI: 10.7150/thno.142919.

NLM

CSE

Song W, Wang J, Gong S, Wang X, Xu J, Wu R, Jiang Z, Zhang H, Wu L, Wang Y, Su Y, Wang H, Gu Y. 2026. FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety: Erratum. Theranostics. 16(16):9557-9558.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See https://ivyspring.com/terms for full terms and conditions.